Major capsid protein L1
From Proteopedia
(Difference between revisions)
Line 5: | Line 5: | ||
== Function == | == Function == | ||
- | Gardasil mimics the <scene name='74/746002/Hpv_monomer_16/1'>HPV virus</scene>, but it does not contain any viral DNA which removes any chance of infection of the HPV virus. This vaccine allows the body to create antibodies against HPV in order to be able to remove the virus if it is introduced in the body. Since the L1 protein is the main structural component of HPV and Gardasil, Gardasil can use this protein to remove HPV from the infected cells <ref name="aus" />. The antibodies provided by Gardasil prevent HPV infection by keeping the virus from entering the epithelial cells of the genitals. However, the antibodies created do not last forever, so the gardasil vaccine will need to be followed up with booster shots<ref> | + | Gardasil mimics the <scene name='74/746002/Hpv_monomer_16/1'>HPV virus</scene>, but it does not contain any viral DNA which removes any chance of infection of the HPV virus. This vaccine allows the body to create antibodies against HPV in order to be able to remove the virus if it is introduced in the body. Since the L1 protein is the main structural component of HPV and Gardasil, Gardasil can use this protein to remove HPV from the infected cells <ref name="aus" />. The antibodies provided by Gardasil prevent HPV infection by keeping the virus from entering the epithelial cells of the genitals. However, the antibodies created do not last forever, so the gardasil vaccine will need to be followed up with booster shots<ref>PMID:23805398</ref>. Since Gardasil is a relatively recent developed vaccine, many specifics are still not known about how it functions. “The exact role of various immune mechanisms in the protective efficacy of the HPV L1 VLP vaccine remains to be determined <ref>http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000703/WC500021140.pdf</ref>.” |
== Structural Highlights== | == Structural Highlights== |
Revision as of 14:40, 5 December 2016
|
References
- ↑ 1.0 1.1 Zhai L, Tumban E. Gardasil-9: A global survey of projected efficacy. Antiviral Res. 2016 Jun;130:101-9. doi: 10.1016/j.antiviral.2016.03.016. Epub, 2016 Apr 1. PMID:27040313 doi:http://dx.doi.org/10.1016/j.antiviral.2016.03.016
- ↑ https://www.gardasil9.com
- ↑ 3.0 3.1 http://www.hpvvaccine.org.au/the-hpv-vaccine/how-does-it-work.aspx
- ↑ 4.0 4.1 https://www.medicines.org.uk/emc/medicine/19016
- ↑ Harper DM, Vierthaler SL, Santee JA. Review of Gardasil. J Vaccines Vaccin. 2010 Nov 23;1(107). pii: 1000107. PMID:23805398 doi:http://dx.doi.org/10.4172/2157-7560.1000107
- ↑ http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000703/WC500021140.pdf
- ↑ doi: https://dx.doi.org/10.1128/JVI.77.8.4818-4826.2003
- ↑ http://dx.doi.org/10.1016/j.virol.2013.05.038
- ↑ http://www.uniprot.org/uniprot/P03101
- ↑ https://www.merck.com/product/usa/pi_circulars/g/gardasil/gardasil_ppi.pdf
- ↑ doi: https://dx.doi.org/10.4161/hv.3.4.4309
- ↑ http://www.fda.gov/BiologicsBloodVaccines/Vaccines/QuestionsaboutVaccines/ucm096052.htm
- ↑ http://www.news-medical.net/health/Histamine-Storage-and-Release.aspx
- ↑ www.westonaprice.org/health-topics/vaccination/adjuvants-in-vaccines/
- ↑ http://www.immune.org.nz/sites/default/files/resources/ConcernVaccineIngredients20140522V01Final.pdf
- ↑ 16.0 16.1 16.2 Murray, Patrick R., Ken S. Rosenthal, and Michael A. Pfaller. "Papillomavirus and Polyomavirus." Medical Microbiology. Philadelphia: Elsevier/Saunders, 2013. 445-450.
Proteopedia Page Contributors and Editors (what is this?)
Morgan Smith, Michal Harel, Jessica Troutman., Maximillia Jackson., Jaime Prilusky